Literature DB >> 21148447

Epigenetics: mechanisms and implications for diabetic complications.

Mark E Cooper1, Assam El-Osta.   

Abstract

Epigenetic modifications regulate critical functions that underlie chromosome metabolism. Understanding the molecular changes to chromatin structure and the functional relationship with altered signaling pathways is now considered to represent an important conceptual challenge to explain diabetes and the phenomenon of metabolic or hyperglycemic memory. Although it remains unknown as to the specific molecular mechanisms whereby hyperglycemic memory leads to the development of diabetic vascular complications, emerging evidence now indicates that critical gene-activating epigenetic changes may confer future cell memories. Chemical modification of the H3 histone tail of lysine 4 and 9 has recently been identified with gene expression conferred by hyperglycemia. The persistence of these key epigenetic determinants in models of glycemic variability and the development of diabetic complications has been associated with these primary findings. Transient hyperglycemia promotes gene-activating epigenetic changes and signaling events critical in the development and progression of vascular complications. As for the role of specific epigenomic changes, it is postulated that further understanding enzymes involved in writing and erasing chemical changes could transform our understanding of the pathways implicated in diabetic vascular injury providing new therapeutic strategies.

Entities:  

Mesh:

Year:  2010        PMID: 21148447     DOI: 10.1161/CIRCRESAHA.110.223552

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  77 in total

Review 1.  Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?

Authors:  Yi-An Ko; Katalin Susztak
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

2.  50 years forward: mechanisms of hyperglycaemia-driven diabetic complications.

Authors:  Nicholas D F Russell; Mark E Cooper
Journal:  Diabetologia       Date:  2015-04-24       Impact factor: 10.122

3.  Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.

Authors:  Zhuo Chen; Feng Miao; Andrew D Paterson; John M Lachin; Lingxiao Zhang; Dustin E Schones; Xiwei Wu; Jinhui Wang; Joshua D Tompkins; Saul Genuth; Barbara H Braffett; Arthur D Riggs; Rama Natarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 4.  Epigenetic Mechanisms in Diabetic Kidney Disease.

Authors:  Merlin C Thomas
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

5.  Remodeling is at the heart of chromatin: the heartaches of chromatin.

Authors:  Assam El-Osta
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

6.  Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.

Authors:  Luciano Pirola; Aneta Balcerczyk; Richard W Tothill; Izhak Haviv; Antony Kaspi; Sebastian Lunke; Mark Ziemann; Tom Karagiannis; Stephen Tonna; Adam Kowalczyk; Bryan Beresford-Smith; Geoff Macintyre; Ma Kelong; Zhang Hongyu; Jingde Zhu; Assam El-Osta
Journal:  Genome Res       Date:  2011-09-02       Impact factor: 9.043

Review 7.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

8.  Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy.

Authors:  Stephen M Cronk; Molly R Kelly-Goss; H Clifton Ray; Thomas A Mendel; Kyle L Hoehn; Anthony C Bruce; Bijan K Dey; Alexander M Guendel; Daniel N Tavakol; Ira M Herman; Shayn M Peirce; Paul A Yates
Journal:  Stem Cells Transl Med       Date:  2015-03-13       Impact factor: 6.940

Review 9.  Hyperglycemia and vascular metabolic memory: truth or fiction?

Authors:  Cristina Bianchi; Roberto Miccoli; Stefano Del Prato
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

10.  Imbalance between HDAC and HAT activities drives aberrant STAT1/MyD88 expression in macrophages from type 1 diabetic mice.

Authors:  Luciano Ribeiro Filgueiras; Stephanie L Brandt; Theresa Raquel de Oliveira Ramalho; Sonia Jancar; C Henrique Serezani
Journal:  J Diabetes Complications       Date:  2016-08-07       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.